KI’s new President: “We need to work closer together”

A closer link between research and education and a stronger “we-feeling” are aims that Annika Östman Wernerson sets out to achieve as the new President of Karol...

Novartis förvärvar strokebolag i mångmiljardaffär

Den schweiziska läkemedelsjätten Novartis förvärvar Anthos Therapeutics för upp till 3,1 miljarder dollar, motsvarande närmare 34 miljarder kronor.

Revealing the secrets of a part

CT inspection in automation technology at Festo.

Agreement in the EU on eight years of data exclusivity for new medicines

New pharmaceuticals will be covered by eight years of data exclusivity, according to the proposed new pharmaceutical legislation that EU countries have now agre...

Kennedy: FDA är en ”marionett” åt läkemedelsindustrin

USA:s nya hälsominister Robert F. Kennedy Jr höll i fredags tal inför läkemedelsmyndigheten FDA:s medarbetare – och tog tillfället i akt att kalla dem för mario...

Lovande resultat för Lillys fetmapiller – skapar börsvågor

Eli Lillys viktminskningspiller överträffar förväntningarna i en fas III-studie och visar resultat i nivå med injicerbara läkemedel som Ozempic. Nyheten fick ak...

”Jag vill vara en trädgårdsmästare som får andra att gro”

Vad innebär det att leda Läkemedelsverket? Nytillträdda Ann Lindberg delar med sig av sina tankar om sin första tid på myndigheten och om de frågor som ligger p...

World Courier (Sweden) AB

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...

Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"

The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

From pharmacist to life science podcaster – Magnus Lejelöv uses his voice as a tool

Magnus Lejelöv has more than 20 years of experience in the pharmaceutical industry and has conducted nearly two hundred interviews with healthcare professionals...

MSD discontinues development of cancer drugs after trial failures

MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.

J&J:s nässpray mot depression godkänns som monoterapi i USA

Johnson & Johnsons nässpray Spravato tillåts nu att användas som fristående behandling vid svår depression.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

Anpassningsbara vridspjällsventiler från OMAL – lösningen för tuffa miljöer

OEM Automatic erbjuder nu vridspjällsventiler från OMAL, särskilt utvecklade för att möta höga krav inom industriella applikationer. Med hög driftsäkerhet, lång...

Rapid development in blood analysis – “Sweden is leading the race”

Thousands of analytical tests using just one single drop of blood. What was revealed as a hoax just a few years ago is now a reality, according to KTH professor...

Ancient DNA provides new insights – “The immune system lost its job”

Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Merck KGaA acquires American company in €3.0 billion deal

Germany’s Merck is completing the acquisition of Springwork Therapeutics for 3 billion euros.

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

Hajpat genterapibolag skär ner med 65 procent

Det en gång så omsusade genterapibolaget Editas Medicine säger upp 65 procent av sin personal – omkring 180 medarbetare – till följd av ett beslut om att avbryt...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...